Subscribe today to receive notice of our latest thought leadership, articles, and updates.
Insights
Open conversations, knowledge sharing, and fresh ideas promote positive change and transparency
Our latest updates, articles and podcasts
Sharing information with the industry is an important part of our mission. Our subject matter experts translate today’s news into comprehensive informational pieces to help you better understand the impact of a recent industry update, trend, or issue.
|
July 01, 2025 · Public Policy & Regulatory Affairs Team
The New York Workers’ Compensation Board (WCB) has adopted rules that modify the regulatory structure of pharmacy direction of care. Read more... |
|
|
June 13, 2025 · Public Policy & Regulatory Affairs Team
This July 1, 2025, the California DWC will update its pharmacy fees schedule for both large volume and smaller pharmacies, as well as for physician dispensers. This will cover fees for drug ingredients and dispensing of prescribed, OTC, and compounded medications. Read more... |
|
May 28, 2025 · Public Policy & Regulatory Affairs Team
Recent updates from California, Colorado, Louisiana, Michigan, Minnesota, Montana, Oklahoma, Oregon, Tennessee, Vermont, and West Virginia. Read more... |
|
|
May 21, 2025 · Public Policy & Regulatory Affairs Team
In preparation for final implementation of the CMS-1500 project and electronic billing requirements, the New York Workers’ Compensation Board is offering stakeholders several educational seminars. Read more... |
|
May 19, 2025 · Clinical Team
On January 30, 2025, Axsome Therapeutics, Inc. announced the U.S. Food and Drug Administration approval of Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo is not indicated for the prevention of migraine attacks or treatment of cluster headache. Read more... |
|
May 15, 2025 · Published by Risk & Insurance
Our annual analysis of prescription transaction data is designed to advise clients on medication utilization trends influenced by state policies, treatment guidelines, and new therapies. This article discusses five medication management trends uncovered from 2024 data, as well as recent policy moves, including potential tariffs, that could impact medications and DME supplies in 2025 and beyond. Read more... |
|
|
May 08, 2025 · Public Policy & Regulatory Affairs Team
Spring is in full bloom – at least in many states. Updates from Alabama, California, Indiana, Montana, New Mexico, New York, Ohio, Tennessee, and West Virginia Read more... |
|
|
May 01, 2025 · Optum
Formulary management and an optimized authorization process work together to support injured worker safety, reduce complexity for adjusters, and prevent unintended billing errors. Read more... |
Page 1 of 5